S

SyntheX, Inc.

21 employees

SyntheX is a biotechnology firm developing highly specific drugs for previously undruggable targets to treat cancer and rare diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Peptides
Ras
Oncology
Pharmaceutical
Cancer Genetics
Synthetic Biology
Biologics
Raf
Molecular glues
Targeted protein degradation
Therapeutics
Synthetic Lethality
Genetic engineering
Drug discovery
Functional Selection
Life Science

Date founded

2016

Funding rounds raised

Total raised

$6.2M

from 10 investors over 10 rounds

S

SyntheX, Inc. raised undisclosed on October 4, 2022

Investors: Bristol-Myers Squibb, UK

S

SyntheX, Inc. raised undisclosed on July 27, 2022

Investors: IndieBio and SOSV - The Accelerator VC

S

SyntheX, Inc. raised undisclosed on September 3, 2020

Investors: IndieBio and SOSV - The Accelerator VC

S

SyntheX, Inc. raised $6.2M on March 1, 2017

Investors: Oriza Ventures, SOSV - The Accelerator VC and 8VC

S

SyntheX, Inc. raised $250K on March 10, 2016

Investors: IndieBio and SOSV - The Accelerator VC

FAQ